StockData
Brainsway Ltd. logo

Brainsway Ltd. (BWAY) stock

BWAYNasdaqSurgical & Medical Instruments & ApparatusAlso trades as BRSYF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 20, 2026Score 5/30
$9.39−0.72 (-7.12%)

Close on Nov 16, 2026Market cap $367.77MP/E 52.2Yield –

Brainsway r&d expenses

Research and development expenses are spending on new products and technology.

Brainsway's R&D Expenses for the twelve months ending Dec 31, 2020 was $5.82M, down 26.1% year over year. For fiscal 2025 it was $9.60M, up 33.6% from the year before. The highest annual figure on record is $9.60M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.60M+33.6%
FY2024Dec 31, 2024$7.19M+7.9%
FY2023Dec 31, 2023$6.67M-13.2%
FY2022Dec 31, 2022$7.68M+20.1%
FY2021Dec 31, 2021$6.39M+9.8%
FY2020Dec 31, 2020$5.82M-26.1%
FY2019Dec 31, 2019$7.88M+27.9%
FY2018Dec 31, 2018$6.16M+15.2%
FY2017Dec 31, 2017$5.34M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020$1.58M–
Q4 FY2019Dec 31, 2019$1.81M–

More Brainsway figures

See a number that looks wrong?